Outset Medical, Inc.
About Outset Medical, Inc.
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $119.5M
- Net income
- -$81.7M
- Total assets
- $264.5M
- Market cap
- $84.9M
- Gross margin
- 39.1%
- Operating margin
- -55.8%
- Net margin
- -68.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $119.5M
- Cost of revenue
- $72.7M
- Gross profit
- $46.8M
- Operating expenses
- $113.5M
- Operating income
- -$66.7M
- Income tax
- $718.0K
- Net income
- -$81.7M
- EPS (basic)
- $-5.37
- EPS (diluted)
- $-5.37
Balance sheet
- Total assets
- $264.5M
- Current assets
- $250.9M
- Total liabilities
- $137.5M
- Current liabilities
- $37.6M
- Shareholders’ equity
- $127.0M
Cash flow
- Operating cash flow
- -$46.3M
- Investing cash flow
- -$97.7M
- Financing cash flow
- $55.5M
- Net cash flow
- -$88.5M
Statements via Polygon.io (SEC filings)
- Market cap
- $84.9M
- EPS (diluted)
- $-5.37
- Shares outstanding
- 19.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 15, 2020
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $81.7M in FY2025.
- Revenue grew 16% from FY2021 to FY2025.
- Gross margin of 39.1%, net margin -68.3%.
- Trading 80% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Outset Medical, Inc..
Write a review
News about Outset Medical, Inc.
News & sentiment via Polygon.io